JC
Jaswanthi Chittabathini
About Jaswanthi Chittabathini
Data last updated:
Jaswanthi Chittabathini is a Director at Kekule Pharma Limited (since 2024) and Director at Ricer Research Private Limited (since 2023). The companies operate in Pharma and Wood. The 2 current companies with reported revenue have a combined latest revenue of ₹145 Cr; the largest is Kekule Pharma Limited at ₹144 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Kekule Pharma Limited U24231TG1984PLC005145 | Director | 13 Feb 2024 | 1984 | ₹144 Cr (FY 2024) | Active |
 Ricer Research Private Limited U20119TS2023PTC174265 | Director | 21 Jun 2023 | 2023 | ₹50 Lakh (FY 2025) | Active |
Board colleagues of Jaswanthi Chittabathini
| Name | DIN | Company | Designation |
|---|---|---|---|
| Harimohan Namdev | Kekule Pharma Limited | Company Secretary | |
| Kudaravalli Durgarani | 01922062 | Kekule Pharma Limited | Whole-Time Director |
| Kudaravalli Raja Rao | 01922050 | Kekule Pharma Limited | Whole-Time Director |
| Kudaravalli Sridhar | 02762498 | Kekule Pharma Limited | Managing Director |
| Nadella Madhava Rao | 00461805 | Kekule Pharma Limited | Director |
| Srilakshmi Kudaravalli | 02762504 | Kekule Pharma Limited | Cfo |
| Srilakshmi Kudaravalli | Kekule Pharma Limited | Cfo | |
| Suman Nadella | 07357230 | Ricer Research Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jaswanthi Chittabathini
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jaswanthi Chittabathini
Jaswanthi Chittabathini currently holds 2 directorships: Kekule Pharma Limited (Director, since 13 Feb 2024, revenue ₹144 Cr (FY 2024)); Ricer Research Private Limited (Director, since 21 Jun 2023, revenue ₹50 Lakh (FY 2025)).
Jaswanthi Chittabathini was first appointed on 21 Jun 2023 as Director at Ricer Research Private Limited. The most recent appointment on record is 13 Feb 2024 at Kekule Pharma Limited.
The 2 current companies of Jaswanthi Chittabathini that report revenue have a combined latest revenue of ₹145 Cr: Kekule Pharma Limited ₹144 Cr (FY 2024); Ricer Research Private Limited ₹50 Lakh (FY 2025).
The current boards of Jaswanthi Chittabathini's companies include Harimohan Namdev (Kekule Pharma Limited), Kudaravalli Durgarani (Kekule Pharma Limited), Kudaravalli Raja Rao (Kekule Pharma Limited), Kudaravalli Sridhar (Kekule Pharma Limited), Nadella Madhava Rao (Kekule Pharma Limited), Srilakshmi Kudaravalli (Kekule Pharma Limited), among others.